
H. Eric Cannon, PharmD, FAMCP
Advertisement
Articles by H. Eric Cannon, PharmD, FAMCP


Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial hypertension (PAH) at a roundtable meeting on December 10, 2016, in Dallas, Texas.
Advertisement
Latest Updated Articles
Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stakeholder Roundtable DiscussionPublished: May 19th 2017 | Updated:
The Economic Impact of Peanut AllergiesPublished: October 19th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
2
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
3
Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data
4
Postpandemic Nursing Home Capacity Declines Tied to Longer Hospital Stays, Increased Patient Travel
5



